PRIA Logo™
TennesseeSB 2499114th General Assembly (2025-2026)Senate

AN ACT to amend Tennessee Code Annotated, Title 4; Title 56 and Title 71, relative to the coverage of long-acting injectable drugs for the treatment or prevention of human immunodeficiency virus.

Sponsored By: Sponsor information unavailable

Failed

TennCare

Personalized for You

How does this bill affect your finances?

Personalize government policy and PRIA will tell you what this bill means for your household, plus every other piece of legislation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.

Free to download

Bill Overview

No Economic Impacts Identified for this Bill

Sponsors & Cosponsors

Sponsors

There is no primary sponsor on record.

Cosponsors

There are no cosponsors for this bill.

Roll Call Votes

No roll call votes available for this bill.

Actions Timeline

  1. Assigned to General Subcommittee of Senate Commerce and Labor Committee

    3/10/2026Senate

  2. Passed on Second Consideration, refer to Senate Commerce and Labor Committee

    3/5/2026Senate

  3. Placed on Senate Commerce and Labor Committee calendar for 3/10/2026

    3/4/2026Senate

  4. Introduced, Passed on First Consideration

    3/2/2026Senate

  5. Approved by Delayed Bills Committee

    3/2/2026Senate

  6. Refer to Senate Delayed Bills Committee

    2/2/2026Senate

  7. Filed for introduction

    2/2/2026Senate

Bill Text

Related Bills

Back to State Legislation